DSS: Redefining Biotechnology & Life Science in India
Tumor Comprehensive Genomic Profiling Panel Assay
The Tumor Comprehensive Genomic Profiling (CGP) Panel Assay is a high-throughput sequencing (NGS)-based solution for the comprehensive analysis of tumor-related genes. Designed for research use only (RUO), it enables precise detection of single nucleotide variations (SNVs), small insertions/deletions (Indels), copy number variations (CNVs), and gene fusions across a 1200-gene panel. Available Test Format: 24 samples/Kit
Hereditary Cancers Panel Assay
The Hereditary Cancers Panel Assay is designed for comprehensive genetic analysis of hereditary tumor-related genes using next-generation sequencing (NGS). This assay enables accurate detection of single nucleotide variations (SNVs) and short insertions/deletions (Indels) across 58 clinically relevant genes associated with hereditary cancer syndromes. Available Test Format: 24 samples/Kit
Human Glioma 26 Gene Mutations Detection Kit (NGS)
The Human Glioma 26 Gene Mutations Detection Kit is a high-throughput sequencing (NGS)-based assay for the qualitative detection of key glioma-associated genetic alterations. Designed for research use only, the kit analyzes nucleic acids extracted from FFPE or fresh tissue samples, enabling detection of SNVs, indels, gene fusions, CNVs, and chromosome variations (1p/19q co-deletion, chr7 amplification, […]
Solid Tumors 107 Gene Mutations Detection Kit (NGS)
The Solid Tumors 107 Gene Mutations Detection Kit is designed for qualitative detection of 107 tumor-related gene mutations using high-throughput sequencing (NGS). Compatible with both Illumina and MGI sequencing platforms, this kit supports detection of SNVs, indels, gene fusions, CNVs, and MSI from FFPE or fresh tissue samples. Sequencing instruments: Illumina sequencing instruments (Miseq, NextSeq […]
Thyroid Cancer Gene Mutation Detection Kit (NGS)
The Thyroid Cancer Gene Mutation Detection Kit is a high-throughput sequencing (NGS) solution designed for the comprehensive detection of key pathogenic mutations associated with thyroid cancer. Using DNA and RNA extracted from fine needle aspiration (FNA) samples or thyroid tissue, the kit covers 16 DNA-level genes and 87 RNA-level genes (209 fusion forms). It detects […]
BRCA1/2 Gene Mutations Detection Kit (High-Throughput Sequencing)
The BRCA1/2 Gene Mutations Detection Kit is designed for the qualitative detection of BRCA1 (NM_007294) and BRCA2 (NM_000059) gene mutations in samples extracted from formalin-fixed paraffin-embedded (FFPE) tissue or peripheral blood of cancer patients. These genes are key biomarkers in hereditary breast and ovarian cancers, consisting of 23 and 27 exons respectively. The assay also […]
Oncology Multi-Gene Mutations Detection Kit (NGS)
“Oncology Multi-Gene Mutations Detection Kit (High-Throughput Sequencing) is designed for the detection of 482 somatic mutations across 13 key cancer-related genes in patients with non-small cell lung cancer and colorectal cancer. Using advanced Next Generation Sequencing (NGS) technology and RingCap®-mediated amplification, it enables precise identification of single-base mutations, insertions, deletions, and gene fusions. The kit […]
PD-L1 IHC 22C3 pharmDx
PD-L1 IHC 22C3 pharmDx Advancing Immunotherapy Options Cytotoxic T cells work to detect and eliminate infected cells and tumor cells from the body.
Antibodies & Controls
Primary Antibodies are intended for use on tissue sections whereas control Reagents are well-suited as qualitative negative controls for the primary antibodies.
PD-L1 IHC 28-8 pharmDx
PD-L1 IHC 28-8 pharmDx Advancing Immunotherapy Options Cytotoxic T cells work to detect and eliminate infected cells and tumor cells from the body.
PathVysion
The PathVysion HER-2 DNA Probe Kit II (PathVysion Kit II) is designed to detect amplification of the HER-2/neu gene via fluorescence in situ hybridization (FISH) in formalin-fixed, paraffin-embedded human breast and gastric cancer tissue specimens.
UroVysion – Products & Solutions
The UroVysion® Bladder Cancer Kit (UroVysion Kit) is FDA approved and designed to detect aneuploidy for chromosomes 3, 7, 17, and loss of the 9p21 locus via fluorescence in situ hybridization (FISH) in urine specimens from persons with hematuria suspected of having bladder cancer.
D001 Hereditary Cancer Panel
SALSA® digital Multiplex Ligation-dependent Probe Amplification (digitalMLPA) is a multiplex PCR followed by Illumina sequencing-based amplicon quantification, for the detection of copy number variations (CNV) and specific point mutations.
Entrogen REAL-TIME PCR KITS FOR SAMPLE QUALITY ASSESSMENT
EntroGen’s Sample Quality Assessment kits provide reagents, positive controls, and standards (if applicable) to detect and quantify the amplifiable DNA extracted from patient samples or adaptor-indexed libraries intended for downstream qPCR and NGS assays, respectively.
Entrogen REAL-TIME PCR KITS FOR THYROID CANCER
Thyroid Cancer Mutation Panel provides reagents for detection of point mutations in BRAF and RAS genes, as well as RET/PTC1, 3 and PAX8/PPARγ fusion genes variants.
Entrogen REAL-TIME PCR KITS FOR MELANOMA
Entrogen's kits are polymerase chain reaction (PCR)-based assays that use allele-specific primers in a multiplex reaction to identify the presence of BRAF, NRAS, and c-Kit mutations. The assays work by amplifying mutant-specific sequences in samples that contain a mixture of mutant and wild-type DNA and rely on fluorescent probes for detection. Each reaction contains primer sets and probes for detection of the mutations, as well as an endogenous control gene.
Frequently Asked Questions
Find answers to common questions about cancer diagnostics, their applications, and selection.
What is cancer diagnostics?
Cancer diagnostics refers to medical tests and technologies used to detect and analyze cancer in the body.
What tests are commonly used for cancer diagnosis?
Common diagnostic methods include molecular testing, biopsy analysis, imaging techniques, and genetic testing.
Why is early cancer diagnosis important?
Early detection increases the chances of successful treatment and improves survival rates.
How does molecular diagnostics help detect cancer?
Molecular diagnostics identifies genetic mutations and molecular markers associated with cancer.
What role do laboratory technologies play in cancer research?
Laboratory technologies help researchers understand cancer biology and develop targeted therapies.
Testimonials & Reviews